Patient characteristics | Resection (n = 15) | Non-resection (n = 43) | Total (n = 58) | p-value |
---|---|---|---|---|
Age (years) | 60.0 ± 10.5 | 62.8 ± 8.4 | 62.1 ± 9.0 | 0.292 |
Male, n (%) | 6 (40.0%) | 28 (65.1%) | 34 (58.6%) | 0.163 |
ECOG score, n (%) | 0.531 | |||
0 | 8 (53.3%) | 17 (39.5%) | 25 (43.1%) | |
1 | 7 (46.7%) | 26 (60.5%) | 33 (56.9%) | |
DM, n (%) | 6 (40.0%) | 20 (46.5%) | 26 (44.8%) | 0.892 |
Tumor size (cm) | 3.7 ± 0.7 | 3.9 ± 1.5 | 3.8 ± 1.3 | 0.434 |
Tumor location, n (%) | 0.542 | |||
Head/neck | 8 (53.3%) | 31 (72.1%) | 39 (67.2%) | |
Body/tail | 7(46.7%) | 12 (27.9%) | 19 (32.8%) | |
Vessel invasion, n (%) | 0.266 | |||
Artery | 2 (13.3%) | 9 (20.9%) | 11 (19.0%) | |
Vein | 0 (0.0%) | 5 (11.6%) | 5 (8.6%) | |
Both | 13 (86.7%) | 29 (67.4%) | 42 (72.4%) | |
CA 19–9 (U/mL) | 576 ± 1,220 | 963 ± 1,833 | 863 ± 1,695 | 0.452 |
CEA (ng/mL) | 9.2 ± 19.3 | 5.4 ± 10.1 | 6.4 ± 13.0 | 0.469 |
FOLFIRINOX cycles [median (range)] | 11 (2–16) | 8 (1–20) | 9 (1–20) | 0.193 |
≥ 6 cycles | 14 (93.3%) | 33 (76.7%) | 47 (81.0%) | 0.304 |
cRDI (%) | 72.6 ± 12.4 | 66.4 ± 15.2 | 68.0 ± 14.7 | 0.164 |
≥ 70% | 8 (53.3%) | 21 (48.8%) | 29 (50.0%) | 1.000 |
BMI (kg/m2) | 22.7 ± 2.6 | 21.3 ± 3.0 | 21.7 ± 2.9 | 0.110 |
SM area (cm2) | 107.4 ± 26.6 | 113.3 ± 24.4 | 111.8 ± 24.9 | 0.435 |
AT area (cm2) | 211.4 ± 66.3 | 198.8 ± 91.9 | 202.1 ± 85.6 | 0.627 |